PURPOSE: We assessed the effect of high partial pressure of arterial carbon dioxide (PaCO2) due to pneumoperitoneum (PP) on growth (height/weight) and development (gross/fine motor function, receptive/expressive communication, and social interaction), by comparing outcome after portoenterostomy (PE) for biliary atresia (BA) using laparoscopic PE (LPE: n = 13) and open PE (OPE: n = 13) cases performed between 2005 and 2014. METHODS: Our PE is based on Kasai's original PE. All data were collated prospectively. RESULTS: Differences in duration of follow-up (LPE: 38.8 months; OPE: 38.1 months), jaundice clearance (LPE: 12/13 = 92.3 %; OPE: 9/13 = 69.2 %), survival with the native liver (LPE: 10/13 = 76.9 %; OPE: 9/13 = 69.2 %), incidence of cholangitis, hypersplenism, and incidence of esophageal varices were not significant. Mean intraoperative PaCO2 was significantly higher in LPE (LPE: 50.1 mmHg; OPE: 40.7 mmHg, p < 0.05). Liver function impairment was not statistically different, although LPE results were slightly worse. There was no overall delay in growth observed, although height/weight gain was more consistent in LPE. The pattern of developmental delay observed was similar for LPE and OPE suggesting that developmental delay is not PE-related; in other words, PP is not implicated in developmental delay. CONCLUSIONS: PP during LPE would appear to have no adverse effects on overall growth/development and liver function in BA patients.
PURPOSE: We assessed the effect of high partial pressure of arterial carbon dioxide (PaCO2) due to pneumoperitoneum (PP) on growth (height/weight) and development (gross/fine motor function, receptive/expressive communication, and social interaction), by comparing outcome after portoenterostomy (PE) for biliary atresia (BA) using laparoscopic PE (LPE: n = 13) and open PE (OPE: n = 13) cases performed between 2005 and 2014. METHODS: Our PE is based on Kasai's original PE. All data were collated prospectively. RESULTS: Differences in duration of follow-up (LPE: 38.8 months; OPE: 38.1 months), jaundice clearance (LPE: 12/13 = 92.3 %; OPE: 9/13 = 69.2 %), survival with the native liver (LPE: 10/13 = 76.9 %; OPE: 9/13 = 69.2 %), incidence of cholangitis, hypersplenism, and incidence of esophageal varices were not significant. Mean intraoperative PaCO2 was significantly higher in LPE (LPE: 50.1 mmHg; OPE: 40.7 mmHg, p < 0.05). Liver function impairment was not statistically different, although LPE results were slightly worse. There was no overall delay in growth observed, although height/weight gain was more consistent in LPE. The pattern of developmental delay observed was similar for LPE and OPE suggesting that developmental delay is not PE-related; in other words, PP is not implicated in developmental delay. CONCLUSIONS: PP during LPE would appear to have no adverse effects on overall growth/development and liver function in BA patients.
Authors: G Galizia; G Prizio; E Lieto; P Castellano; L Pelosio; V Imperatore; A Ferrara; C Pignatelli Journal: Surg Endosc Date: 2000-12-21 Impact factor: 4.584
Authors: Kin Wai Edwin Chan; Kim Hung Lee; Jennifer Wai Cheung Mou; Sing Tak Gloria Cheung; Yuk Him Peter Tam Journal: Pediatr Surg Int Date: 2011-02-01 Impact factor: 1.827
Authors: Ninh T Nguyen; Scott Braley; Neal W Fleming; Lindsey Lambourne; Ryan Rivers; Bruce M Wolfe Journal: Am J Surg Date: 2003-07 Impact factor: 2.565
Authors: J G Mogilner; H Bitterman; L Hayari; V Brod; A G Coran; R Shaoul; M Lurie; S Eldar; I Sukhotnik Journal: Eur J Pediatr Surg Date: 2008-12-05 Impact factor: 2.191
Authors: Ma Lishuang; Chen Zhen; Qiao Guoliang; Zhang Zhen; Wang Chen; Li Long; Liu Shuli Journal: Pediatr Surg Int Date: 2015-01-28 Impact factor: 1.827
Authors: David Eugenio Hinojosa-Gonzalez; Luis C Bueno; Andres Roblesgil-Medrano; Gustavo Salgado-Garza; Sofia Hurtado-Arellano; Juan S Farias; Mauricio Torres-Martinez; Jaime A Escarcega-Bordagaray; Marcelo Salan-Gomez; Eduardo Flores-Villalba Journal: Pediatr Surg Int Date: 2021-07-16 Impact factor: 1.827